Molecular Partners (Switzerland) Price on February 20, 2023
| MOLN Stock | CHF 4.44 0.19 4.10% |
If you're considering investing in Molecular Stock, it is important to understand the factors that can impact its price. As of today, the current price of Molecular Partners stands at 4.44, as last reported on the 29th of December, with the highest price reaching 4.68 and the lowest price hitting 4.44 during the day. At this stage we consider Molecular Stock to be very risky. Molecular Partners has Sharpe Ratio of 0.0321, which conveys that the firm had a 0.0321% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Molecular Partners, which you can use to evaluate the volatility of the firm. Please verify Molecular Partners' Mean Deviation of 4.09, downside deviation of 4.85, and Risk Adjusted Performance of 0.0494 to check out if the risk estimate we provide is consistent with the expected return of 0.19%.
Molecular Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Molecular |
Sharpe Ratio = 0.0321
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MOLN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.99 actual daily | 53 53% of assets are less volatile |
Expected Return
| 0.19 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Molecular Partners is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Molecular Partners by adding it to a well-diversified portfolio.
Molecular Partners Valuation on February 20, 2023
It is possible to determine the worth of Molecular Partners on a given historical date. On February 20, 2023 Molecular was worth 5.8 at the beginning of the trading date compared to the closed value of 5.87. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Molecular Partners stock. Still, in general, we apply an absolute valuation method to find Molecular Partners' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Molecular Partners where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Molecular Partners' related companies.
| Open | High | Low | Close | Volume | |
| 5.81 | 5.85 | 5.79 | 5.79 | 14,038 | |
02/20/2023 | 5.80 | 6.00 | 5.80 | 5.87 | 10,157 |
| 5.92 | 5.98 | 5.80 | 5.84 | 11,449 |
| Backtest Molecular Partners | | | Molecular Partners History | | | Molecular Partners Valuation | Previous | Next |
Molecular Partners Trading Date Momentum on February 20, 2023
| On February 21 2023 Molecular Partners AG was traded for 5.84 at the closing time. The highest price during the trading period was 5.98 and the lowest recorded bid was listed for 5.80 . The volume for the day was 11.4 K. This history from February 21, 2023 contributed to the next trading day price decline. The trading delta at closing time to the next closing price was 0.51% . The trading delta at closing time to the current price is 2.21% . |
Molecular Partners Fundamentals Correlations and Trends
By evaluating Molecular Partners' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Molecular Partners' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Molecular financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Molecular Partners Stock history
Molecular Partners investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Molecular is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Molecular Partners will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Molecular Partners stock prices may prove useful in developing a viable investing in Molecular Partners
Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland. MOLECULAR PARTNERS operates under Biotechnology classification in Switzerland and is traded on Switzerland Exchange. It employs 163 people.
Molecular Partners Stock Technical Analysis
Molecular Partners technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Molecular Partners Period Price Range
Low | December 29, 2024
| High |
0.00 | 0.00 |
Molecular Partners AG cannot be verified against its exchange. Please verify the symbol is currently traded on SIX Swiss Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Molecular Partners December 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Molecular Partners stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Molecular Partners shares will generate the highest return on investment. By undertsting and applying Molecular Partners stock market strength indicators, traders can identify Molecular Partners AG entry and exit signals to maximize returns
Molecular Partners Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Molecular Partners' price direction in advance. Along with the technical and fundamental analysis of Molecular Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Molecular to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0494 | |||
| Jensen Alpha | 0.3057 | |||
| Total Risk Alpha | 0.1294 | |||
| Sortino Ratio | 0.0564 | |||
| Treynor Ratio | (0.66) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Molecular Stock Analysis
When running Molecular Partners' price analysis, check to measure Molecular Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Molecular Partners is operating at the current time. Most of Molecular Partners' value examination focuses on studying past and present price action to predict the probability of Molecular Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Molecular Partners' price. Additionally, you may evaluate how the addition of Molecular Partners to your portfolios can decrease your overall portfolio volatility.